Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

Recent Healthcare Stocks Articles

Why Is LumiraDx (LMDX) Stock Down 13% Today?

LumiraDx stock is falling hard on Monday as investors in LMDX prepare for the company's shares to be delisted on Tuesday!

3 Unstoppable S&P 600 Small-Cap Stocks to Buy in January

Small-cap stocks tend to outperform mid- and large-cap stocks over time and make for an important component of a balanced portfolio.

Why Is Cellectar Biosciences (CLRB) Stock Up 16% Today?

Cellectar Biosciences stock is up on Monday as investors celebrate positive study results with heavy trading of CLRB stock this morning.

Why Is Harpoon Therapeutics (HARP) Stock Up 111% Today?

Harpoon Therapeutics stock is rocketing higher on Monday as HARP investors react to Merck acquiring the company for $23 per share.

$10K to $100K: Small-Cap Marvels With Massive Upside

Unlocking the potential of small-cap companies often reveals sky-bound stocks. The three listed stocks in the article offer substantial growth opportunities.

Beyond Biotech: 3 Companies Breaking Ground in the Longevity Space

Longevity opportunity - for investors and lifespan lengtheners - goes beyond biotech with these companies offering actionable products.

3 Stocks to Make You the Millionaire Next Door: 2024 Edition

Investors wanting to maximize the gains in their portfolio should take a position in one of these leading companies.

Allogene Layoffs 2024: What to Know About the Latest ALLO Job Cuts

Today, investors in Allogene and ALLO stock aren't cheering a cash burn reduction strategy, with the stock sinking over 15% on the news.

New SAVAW Warrants Are Trading After Cassava Sciences’ Distribution

Following a distribution, investors in Cassava Sciences and SAVA stock now have some warrants to factor into their models today.

HGEN Stock Alert: Why Humanigen Just Filed for Ch. 11 Bankruptcy

Humanigen stock is falling hard on Friday as investors in HGEN sell shares after the company announced a bankruptcy filing.

AlloVir Layoffs 2024: What to Know About the Latest ALVR Job Cuts

AlloVir layoffs are coming for 95% of the company's employees as a way to reduce costs and preserve cash after failed clinical trials.

Why Is Medical Properties Trust (MPW) Stock Down 31% Today?

Medical Properties Trust stock is falling hard on Friday as investors in MPW react to a rent repayment plan with Steward Health Care System.

Intellia Therapeutics Layoffs 2024: What to Know About the Latest NTLA Job Cuts

Intellia Therapeutics layoffs are in the news on Friday as the biotech company prepares to cut its total workforce by 15% to reduce costs.

Why Is Applied Therapeutics (APLT) Stock Down 30% Today?

Applied Therapeutics stock is tumbling on Friday as investors react to lackluster results from a Phase 3 clinical trial of AT-001.

Why Is Dermata Therapeutics (DRMA) Stock Up 62% Today?

Dermata Therapeutics stock is heading higher on Friday as investors of DRMA shares react to a new patent for DMT410 in Japan.

Why Is Ainos (AIMD) Stock Up 157% Today?

Ainos stock is up on Friday as shares of AIMD see heavy trading despite a lack of news from the healthcare company today.

7 F-Rated Stocks to Sell for January 2024

There's no reason to have F-rated stocks in your portfolio. Get rid of these stocks to sell before they do some real damage.

Tilray’s Downfall: Why TLRY Stock Isn’t the High Investors Hoped For

With its share price down 92% since its 2018 market debut, and now trading as a penny stock, there doesn't appear to be much hope left for cannabis producer Tilray Brands.

Global Giants: 3 Multinational Corporations to Outperform in 2024

Participate in the growth of the global economy and consumption through these leading global stocks for 2024.